<SEC-DOCUMENT>0000950170-25-053707-index.html : 20250414
<SEC-HEADER>0000950170-25-053707.hdr.sgml : 20250414
<ACCEPTANCE-DATETIME>20250414160743
ACCESSION NUMBER:		0000950170-25-053707
CONFORMED SUBMISSION TYPE:	ARS
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250414
DATE AS OF CHANGE:		20250414
EFFECTIVENESS DATE:		20250414

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kyverna Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001994702
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				831365441
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		ARS
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41947
		FILM NUMBER:		25836101

	BUSINESS ADDRESS:	
		STREET 1:		5980 HORTON STREET
		STREET 2:		SUITE 550
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		5106268331

	MAIL ADDRESS:	
		STREET 1:		5980 HORTON STREET
		STREET 2:		SUITE 550
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
</SEC-HEADER>
<DOCUMENT>
<TYPE>ARS
<SEQUENCE>1
<FILENAME>kytx_2024_asr_annual_rep.pdf
<DESCRIPTION>ARS
<TEXT>
Document 1 - file: kytx_2024_asr_annual_rep.pdf

</DOCUMENT>
</SEC-DOCUMENT>